A phase I, first‐in‐human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937.

Autor:	Benn, Paul D.1 (AUTHOR) paul.d.benn@viivhealthcare.com, Zhang, Ying2 (AUTHOR), Kahl, Lesley1 (AUTHOR), Greene, Thomas J.2 (AUTHOR), Bainbridge, Veronica3 (AUTHOR), Fishman, Cindy2 (AUTHOR), Wen, Bo2 (AUTHOR), Gartland, Martin4 (AUTHOR)
Zdroj:	Pharmacology Research & Perspectives. Jun2023, Vol. 11 Issue 3, p1-12. 12p.
Databáze:	Academic Search Ultimate
Externí odkaz: